Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2025-12-26 @ 3:29 AM
Study NCT ID:
NCT04156620
Status:
COMPLETED
Last Update Posted:
2024-06-18
First Post:
2019-10-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-11
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-20
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-08
First Submit QC Date:
None
Study First Post Date:
2019-11-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-11-24
Results First Submit QC Date:
None
Results First Post Date:
2024-01-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-01-23
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-06-14
Last Update Post Date:
2024-06-18
Last Update Post Date Type:
ACTUAL